MedPath

Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection

Phase 2
Completed
Conditions
Chronic HBV Infection
Interventions
Registration Number
NCT04147208
Lead Sponsor
Sunshine Lake Pharma Co., Ltd.
Brief Summary

The experiment is divided into two parts: Part 1 and Part 2.Part 1 was the initial treatment patient and Part 2 was the treated patient.

Detailed Description

About 125 subjects were planned to be included and assigned to the experimental group and the control group according to 4:1.At the same time, a liver biopsy group was set up in each part of the population to receive liver biopsy during the screening period and 48 weeks after completion of drug administration, which was used to detect HBV DNA, cccDNA, HBsAg, and evaluate the degree of liver inflammation and fibrosis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Chronic HBV infection population
  • HBeAg positive
  • HBsAg≥250 IU/mL
  • No cirrhosis
Exclusion Criteria
  • AST>5×ULN
  • Platelet count less than 90E+09/L
  • TBil>1.5×ULN
  • albumin<35 g/L
  • INR>1.5
  • AFP>50 ng/mL

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Combination groupGLS4Subjects will receive 96 weeks of GLS4+RTV+ETV.
Combination groupETVSubjects will receive 96 weeks of GLS4+RTV+ETV.
Entecavir monotherapyETVSubjects received 96 weeks of entecavir treatment
Combination groupRTVSubjects will receive 96 weeks of GLS4+RTV+ETV.
Primary Outcome Measures
NameTimeMethod
The value of serum HBsAg decreased from baseline48 weeks after dosing

The value of serum HBsAg at 48 weeks of treatment was lowered compared with baseline.

Secondary Outcome Measures
NameTimeMethod
The value of HBV DNA decreased from baseline24 weeks after dosing

The value of HBV DNA at 24 weeks of treatment was lowered compared with baseline.

The value of serum HBeAg decreased from baseline24 weeks after dosing

The value of serum HBeAg at 24 weeks of treatment was lowered compared with baseline.

The value of serum HBsAg decreased from baseline24 weeks after dosing

The value of serum HBsAg at 24 weeks of treatment was lowered compared with baseline.

Trial Locations

Locations (37)

Beijing Ditan Hospital Affiliated to Capital Medical University

🇨🇳

Beijing, Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

Beijing YouAn Hospital,Capital Medical University

🇨🇳

Beijing, Beijing, China

The second affiliated hospital of ChongQing medical university

🇨🇳

Chongqing, Chongqing, China

The first affiliated hospital of ChongQing medical university

🇨🇳

Chongqing, Chongqing, China

Mengchao Hepatobiliary Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

The First Hospital of Lanzhou University

🇨🇳

Lanzhou, Gansu, China

Guangzhou Eighth People's Hospital

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

The third affiliated hospital of sun yat-sen university

🇨🇳

Guangzhou, Guangdong, China

The first affiliated hospital of Guangxi medical university

🇨🇳

Nanning, Guangxi, China

Affiliated hospital of Guizhou medical university

🇨🇳

Guiyang, Guizhou, China

Affiliated hospital of ZunYi medical college

🇨🇳

Zunyi, Guizhou, China

Hainan General Hospital

🇨🇳

Haikou, Hainan, China

The fourth affiliated hospital of Harbin medical university

🇨🇳

Harbin, Heilongjiang, China

Henan Provincial People's Hospital

🇨🇳

Zhengzhou, Henan, China

The Central Hospital of Wuhan

🇨🇳

Wuhan, Hubei, China

Xiangya Hospital, Central South University

🇨🇳

Changsha, Hunan, China

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University Science & Technology

🇨🇳

Wuhan, Hubei, China

The People's Liberation Army No.81 Hospital

🇨🇳

Nanjing, Jiangsu, China

The Second Hospital of Nanjing

🇨🇳

Nanjing, Jiangsu, China

Nanjing Gulou Hospital

🇨🇳

Nanjing, Jiangsu, China

The Third People's Hospital of Zhenjiang

🇨🇳

Zhenjiang, Jiangsu, China

The first hospital of jilin university

🇨🇳

Chang chun, Jilin, China

The second hospital of jilin university

🇨🇳

Changchun, Jilin, China

Qingdao municipal hospital

🇨🇳

Qingdao, Shandong, China

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

Huashan Sub-Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Shanghai putuo district central hospital

🇨🇳

Shanghai, Shanghai, China

Shanghai Public Health Clinical Center

🇨🇳

Shanghai, Shanghai, China

The second affiliated hospital of air force medical university

🇨🇳

Xi'an, Shanxi, China

The First Affiliated Hospital of Xi'an Jiaotong University

🇨🇳

Xi'an, Shanxi, China

West China Hospital, Sichuan University

🇨🇳

Chengdu, Sichuan, China

Sichuan Provincial People's Hospital

🇨🇳

Chengdu, Sichuan, China

Tianjin third central hospital

🇨🇳

Tianjing, Tianjing, China

The First Affiliated Hospital of Wenzhou Medical University

🇨🇳

Wenzhou, Zhejiang, China

Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath